Study of Danggui Buxue Decoction in Preventing Neutropenia
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
To evaluate EC/TC (epirubicin and cyclophosphomide or docetaxel and cyclophosphomide) with
EC/TC plus DBD (Danggui Buxue Decoction) in adjuvant treatment of breast cancer patients. The
aim is to evaluate whether DBD can decrease the incidence of grade 3/4 neutropenia induced by
EC/TC regimen during chemotherapy.